Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.

Dressel, A

Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis. [electronic resource] - Acta neurologica Scandinavica Dec 2006 - 368-73 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0001-6314

10.1111/j.1600-0404.2006.00700.x doi


Adjuvants, Immunologic--pharmacology
Adolescent
Adult
Cell Culture Techniques
Cell Proliferation--drug effects
Cytokines--metabolism
Female
Humans
Interferon beta-1b
Interferon-beta--pharmacology
Interleukin-10--blood
Leukocytes, Mononuclear--drug effects
Male
Middle Aged
Multiple Sclerosis, Chronic Progressive--blood